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C O M P A R A T I V E STUDY OF H O R M O N A L COUNTER-
R E G U L A T I O N D U R I N G GCIIS-GUIDED INSULIN 
H Y P O G L Y C E M I A TESTS USING H U M A N INSULIN 
(RECOMBINANT DNA) A N D PORK INSULIN 
G . M Ü L L E R - E S C H , 1 P . B A L L , 2 U . B E K E M E Y E R , 1 K . H E I D B Ü C H E L , 1 E . K R A A S , 3 C. V . D . L Ü H E , 1 R . 
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(Received 27 August 1984) 
S U M M A R Y Human insulin (BHI, recombinant DNA) and 
pork insulin (PI) were compared in 10 healthy volunteers. Using 
a glucose controlled insulin infusion System for the Performance 
of the insulin hypoglycemia test (IHT), a comparable dosage 
of both insulins had to be infused (BHI 0-129 ±0-007 vs PI 
0 1 1 5 ± 0 0 1 U/kg; mean±SEM). Blood glucose slopes and nadirs 
did not differ significantly (BHI 30 ± 2 vs PI 29 ± 2 mg/dl). There 
was no difference in C-peptide inhibition (minimum for BHI 
0 - 5 0 ± 0 0 8 vs PI 0-42±0-08ug/1). Maximum hormoneresponses 
were identicalfor A C T H (BHI 78-4+11-3 vs PI 76-0±8-7 pg/ml), 
cortisol (BHI 2 4 6 ± 2 0 vs PI 2 5 2 ± 1 5 n g / m l ) and G H (BHI 
43-8 + 7-3 vs PI 49-4±6-7ng/ml) . Peak levels of prolactin did 
not differ significantly (BHI 1,335 + 315 vs PI 1,766 ± 6 1 4 uU/ml). 
The urinary excretion pattern of epinephrine in three 120 min 
periods before, during and after IHT was identical (before IHT: 
BHI 0-9 + 0-2 vs PI 0 - 6 ± 0 - l u g / 1 2 0 m i n ; during IHT: BHI 
12-6 + 2-2 vs PI 13-4 ± 2-5 ug/120 min; after IHT: BHI 2-5 ±0-7 vs 
PI 3-7 ±1-3 |ig/120 min). No differences in the minima of serum 
potassium levels were observed (BHI 3-38±0-04 vs PI 3*33 + 
0 05 mmol/1). 
We conclude that the biological effects of human insulin and 
pork insulin are comparable. Our data do not support the 
assumption of a different hypothalamic handling of human 
insulin (recombinant DNA) and porcine insulin. 
K e y w o r d s : Human insulin (recombinant DNA), insulin hypo-
glycemia test, glucose controlled insulin infusion System 
I N T R O D U C T I O N 
S T U D I E S comparing the effect of human insulin (recom-
binant D N A ) and pork insulin on hormonal counter-
regulation after insulin-induced hypoglycemia have yielded 
contradictory results up to now (1-6). Concerning the 
counter-regulatory response of cortisol and growth hor-
mone, a diminished as well as an increased secretion was 
reported (4,7). Moreover, both decreased and increased 
inhibition of endogenous insulin secretion was observed 
(4,5). Furthermore, Rosak and co-workers (5) found a 
Correspondence: Dr. G. Müller-Esch, Klinik für Innere Medizin, 
Medizinische Hochschule Lübeck, D-24 Lübeck 1, Ratzeburger Allee 
160, West Germany. 
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blunted or deficient prolactin response under human 
insulin, whereas Petersen e t a l (3) noticed that injection of 
human insulin resulted in less pronounced hypokalemia 
and epinephrine secretion. O n the other hand, Landgraf 
(2) was not able to show any significant differences in 
counter-regulatory hormone responses. 
Among these conflicting data, the differences in serum 
potassium, prolactin and epinephrine secretion, which 
may reflect a different hypothalamic handling of the 
insulins, are perhaps of clinical importance. However, as a 
result of very different insulin doses used in these studies, 
the comparability is limited. We therefore used a glucose 
controlled insulin infusion system (GCHS) in order to 
perform the insulin hypoglycemia test (IHT) on the basis 
of a standardized hypoglycemia (8). 
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M A T E R I A L S A N D M E T H O D S 
Ten healthy volunteers (4 female, 6 male; 25 + 0-9yr; 1 7 4 ± 4 c m ; 
66 ± 4 kg; (mean + SEM)) were studied after informed consent. Each 
subject underwent 2 insulin hypoglycemia tests: one with human insulin 
of recombinant DNA origin (Biohumaninsulin normal, ELI LILLY GMBH) 
and one with pork insulin (Insulin S, HOECHST). 
Glucose Controlled I n s u l i n Infusion System 
The details of the GCIIS used for our study (Biostator, LIFE SCIENCE 
INSTRUMENTS, MILES LABORATORIES) have been described elsewhere (9-11). 
The Biostator was used on static control. The following constants were 
chosen: BI35, QI10, RI 20, FI 300. 
E x p e r i m e n t e l l Protocol 
After an overnight fast and bed rest, the subjects were connected to the 
GCIIS between 8 am and 9 am. Feedback controlled insulin infusion 
was discontinued and the device was only used for blood glucose 
monitoring when blood glucose had fallen below 40 mg/dl and initial 
clinical Symptoms of hypoglycemia like palpitations, headache, sweating, 
tachycardia and drowsiness occurred (8). Venous blood samples were 
drawnat -10, ± 0 , +10, +20, +30, +40, +60, +90 and + 120min, 
respectively, from an indwelling catheter placed in an antecubital vein. 
In addition, urine was collected during three 120 min periods before, 
during and after IHT. 
A n a l y t i c a l Methods 
Serum G H (CIS), prolactin (CIS), cortisol (clinical assays, SP), 
A C T H (INC, without extraction), insulin (CIS) and C-peptide (BYK 
Mallinckrodt) were measured by radioimmunoassay. Serum potass-
ium was determined by flame photometry. Urinary epinephrine was 
measured by H P L C with electrochemical detection (12). 
Infused insulin (U/kg) 
PI ; x • SEM 
B6(mg/dl) 
100-
80-
60 
40-
20 
-10 ±0 10 20 30 40 60 90 120 min 
FIG. 1. Infused insulin and blood glucose levels during GCIIS-guided 
IHT with BHI O O and PI • • in 10 healthy volunteers 
(mean + SEM). 
Statistical Methods 
Results are expressed as mean + SEM. Wilcoxon's t-test for paired 
differences and analyses of variance (repeated measures over time) were 
used (13). 
R E S U L T S 
Figures 1-4 and Table 1 show the results obtained with 
biosynthetic human insulin (BHI) and pork insulin (PI). 
The curves were obtained by calculating the mean values ± 
S E M at identical timepoints, whereas Table 1 gives the 
results obtained by calculating the mean + S E M of the 
individual peak or nadir levels, which differed slightly in 
time from the overall means. 
A total of 0-129 ± 0 0 0 7 U A g B H I and 0115 ± 0 0 1 U/kg 
PI was given by the GCI IS (no statistically significant 
difference). Blood glucose values did not differ signifi-
cantly for both insulins during I H T (fig. 1). The lowest 
blood glucose concentration was 30 ± 2 for BHI and 
29 ± 2 for PI (not significant). 
Peak values for serum insulin did not differ significantly 
(214 + 34 for B H I vs 172 ± 14 mU/1 for PI), whereas serum 
insulin levels at 20 min were higher for B H I than for PI 
(151 ± 16 vs 2 1 4 ± 3 4 m U / l ; p < 005). 
120 min 
FIG. 2. Serum insulin and serum C-peptide concentrations during 
GCIIS-guided IHT with BHI O O and PI • # in 10 healthy 
volunteers (mean + SEM). 
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Prolactin (/jU/ml) 
Cortisol (ng/ml) 
-10 ±0 10 20 30 45 60 90 120 min -10 ±0 10 20 30 45 60 90 120 min 
FIG. 3. Serum levels for A C T H , cortisol, G H and prolactin during GCIIS-guided IHT with BHI O O and PI # # in 10 healthy volunteers 
( m e a n ± S E M ) . 
Following B H I and PI administration, an identical 
pattern of C-peptide inhibition could be demonstrated 
(fig. 2). A C T H and cortisol responses were indentical for 
B H I and PI (fig. 3). A C T H reached its maximum at 
45 min with 78-4± 11 -3 pg/ml for B H I vs 76-0 + 8-7 pg/ml 
for P L Peak values for cortisol, observed at 90 min, 
were 2 4 6 ± 2 0 n g / m l for B H I and 2 5 2 ± 1 5 ng/ml for PI, 
respectively. 
Identical slopes were obtained for G H . The maximal 
hormone response values were 43-8±7-3ng/ml for B H I 
and 49-4 ±6-7 ng/ml for P I ; the difference was statistically 
not significant. The same was true with prolactin secretion. 
After administration of both insulins, prolactin reached 
its maximum after 60 min: 1,335 ± 315 uU/ml (BHI) and 
1,766 ± 614 uU/ml (PI). Although prolactin levels follow-
ing B H I administration tended to be lower than after PI, a 
statistically significant difference could not be detected 
(% 3). 
Following insulin administration, the decline of serum 
potassium was virtually identical (fig. 4). The minimal 
values were 3-38±0-04mmol/1 (BHI) and 3-33±0-05 
mmol/1 (PI). 
The urinary excretion pattern of epinephrine, as evalu-
ated by its content in three 120 min periods before, during 
and after IHT, did not differ significantly: during I H T 
12-6 +2-2jig for B H I vs 13-4±2-5ug for PI ; after I H T 
2-5 ±0-7 (ig for BHI vs 3-7± 1 -3 for PI. 
D l S C U S S I O N 
The aim of this investigation was to study the counter-
regulatory effects following B H I and PI administration 
during standardized hypoglycemia achieved by auto-
matic adjustment of insulin delivery to the individual 
insulin sensitivity by means of the GCIIS (8). As shown, 
nearly identical amounts of infused insulin produced 
comparable serum insulin peaks and resulted in identical 
blood glucose responses. So we feel that—in spite of some 
minor differences in serum insulin levels, which may be in 
part attributed to the different insulin formulations (14) — 
the results obtained with B H I and PI are comparable. 
G L U C O S E C O N T R O L L E D INSULIN INFUSION SYSTEM 123 
The inhibition pattern of endogenous insulin secretion 
during I H T as reflected by serum C-peptide levels showed 
no differences after BHI and PI. 
N o differences in glucose counter-regulation with re-
gard to the hypothalamic-pituitary-adrenocortical axis 
could be detected. 
Furthermore, we were not able to see a deficient pro-
lactin response during I H T as reported by others (5). The 
failure to detect any statistically significant difference in 
prolactin secretion does not necessarily imply that the 
hormonal responses for both insulins are identical, be-
cause of the large Standard deviation in a limited number 
of subjects. However, it is doubtful, whether a blunted 
response, which has recently been shown only after 
a dosage of 0 0 7 5 U / k g insulin (2,5), has any clinical 
importance. 
With the assumption that the epinephrine secretion is 
reflected with sufficient reliability by the urinary epine-
phrine excretion during the collection periods, no differ-
ences in counter-regulatory epinephrine responses could 
be demonstrated. A distinct decrease of serum potassium 
concentrations occurs during insulin-induced hypogly-
cemia. The initial decline is due to the insulin-induced 
cell-influx, whereas the second phase after blood glucose 
recovery is attributed to epinephrine secretion in response 
to hypoglycemia (5,15,16). According to the identical 
epinephrine excretion pattern, we could not find any 
differences in serum potassium concentrations during 
IHT. These findings confirm recent data (2), but are in 
contrast to Petersen and co-workers (3) who described 
less pronounced changes in serum potassium and epine-
phrine after injection of 0T U / k g B H I when compared to 
an identical pork insulin formulation. 
Table 1 Mean basal values (bas.) and maximum (max.) or minimum (min.) levels obtained during GCIIS-guided 
IHT with BHI and PI for blood glucose (BG), C-peptide, prolactin, A C T H , cortisol, G H , serum potassium and 
urinary epinephrine in 10 healthy volunteers (mean ± SEM) 
B G (mg/dl) C-peptide {p.g/1) P r o l a c t i n {pU/ml) 
bas. m i n . bas. m i n . bas. max. 
BHI 85 + 3 3 0 ± 2 1 - 2 5 ± 0 1 0 0-50 + 008 2 1 4 ± 2 4 1,335±315 
PI 7 9 ± 3 29 + 2 1 08+008 0-42 + 008 207 ± 2 5 1 ,766±614 
A C T H {pg/ml) Cortisol {ng/ml) G H {ng/ml) 
bas. max. bas. max. bas. max. 
BHI 16-7 + 2-2 7 8 - 4 ± l l - 3 85 + 11 246 ± 2 0 1-3 ± 0 - 4 43-8±7-3 
PI 1.8-5 + 2-6 76-0 + 8-7 94 + 9 252+15 2-3 ± 1 0 49-4 ±6-7 
Potassium { mmoljl) U r i n a r y epinephrine {p.g/120 m i n ) 
bas. m i n . before d u r i n g after I H T 
BHI 4-29 ± 0 0 9 3-38 + 004 0-9±0-2 12-6 ±2*2 2-5±0-7 
PI 4 -30±0-04 3 - 3 3 ± 0 0 5 0-6 ± 0 1 13-4±2-5 3-7 ±1-3 
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FIG. 4. Urinary epinephrine betöre, during and after GCIIS-guided 
IHT with BHI • and PI E3 in 10 healthy volunteers (mean ± S E M ) . 
Serum potassium concentrations for BHI O O and PI • # are 
also shown (mean ± SEM). 
We conclude that the biological effects of human in-
sulin (recombinant D N A ) and pork insulin are com-
parable. Our data do not support the assumption of a 
different hypothalamic handling of human and porcine 
insulin (3,6) which might have been of clinical importance 
in diabetes treatment. 
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